
Research at ObesityWeek 2026 tracks rising obesity in Medicare, productivity losses, prior authorization denials, and GLP-1 persistence.
https://www.pharmacytimes.org/on-demand/an-american-journal-of-managed-care-ajmc-2part-supplement-current-new-and-emerging-therapies-for-the-prevention-and-management-of-migraine





